MCCALL GARDNER: Open Payments
NPI 1952014573 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,954 in 162 payments from 21 companies in 2025. Trend: 2023 $4,080 · 2024 $4,556 · 2025 $2,954
Food & beverage: $2,954
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $788 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $507 |
| Neurocrine BioSciences, Inc. | 16 | $329 |
| Otsuka America Pharmaceutical, Inc. | 11 | $178 |
| Almatica Pharma LLC | 10 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $159 |
| Axsome Therapeutics, Inc. | 12 | $148 |
| Alkermes, Inc. | 9 | $135 |
| Lundbeck LLC | 4 | $88 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, REXULTI, LOREEV XR, TRINTELLIX, Auvelity, ARISTADA.
Industry payments across NC — which companies pay providers there.
